Carrolee Barlow

Insider Reports History

Location
Rockville, MD
Signature
/s/ Timothy C. Dec, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Carrolee Barlow:

Company Role Class Num Shares Value Price $ Report Date Ownership
SUPERNUS PHARMACEUTICALS, INC. Director Common Stock 22,570 $896,029 $39.70 22 Feb 2025 Direct
SUPERNUS PHARMACEUTICALS, INC. Director Restricted Stock Unit 2,989 $177,658 $39.70 18 Feb 2026 Direct
SUPERNUS PHARMACEUTICALS, INC. Director Restricted Stock Units 0 $0 $39.70 22 Feb 2025 Direct
SUPERNUS PHARMACEUTICALS, INC. Director Director Stock Option (Right to Buy) 4,977 18 Feb 2026 Direct

Insider Reports Filed by Carrolee Barlow

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SUPN SUPERNUS PHARMACEUTICALS, INC. 18 Feb 2026 2 $0 4 Director 20 Feb 2026, 16:44
SUPN SUPERNUS PHARMACEUTICALS, INC. 22 Feb 2025 2 $0 4 Director 24 Feb 2025, 17:43
SUPN SUPERNUS PHARMACEUTICALS, INC. 19 Feb 2025 2 $0 4 Director 21 Feb 2025, 16:47
SUPN SUPERNUS PHARMACEUTICALS, INC. 23 Feb 2024 2 $0 4 Director 27 Feb 2024, 17:04
SUPN SUPERNUS PHARMACEUTICALS, INC. 22 Feb 2024 2 $0 4 Director 26 Feb 2024, 17:02
SUPN SUPERNUS PHARMACEUTICALS, INC. 23 Feb 2023 2 $0 4 Director 27 Feb 2023, 16:01
SUPN SUPERNUS PHARMACEUTICALS, INC. 22 Feb 2023 2 $0 4 Director 24 Feb 2023, 16:12
SUPN SUPERNUS PHARMACEUTICALS, INC. 22 Feb 2022 2 $0 4 Director 24 Feb 2022, 20:24
SUPN SUPERNUS PHARMACEUTICALS, INC. 19 Feb 2022 2 $0 4 Director 23 Feb 2022, 15:19